Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NHI) provides essential updates for stakeholders tracking this healthcare-focused REIT. This page aggregates official announcements and strategic developments related to senior housing financing, medical facility transactions, and operational partnerships.
Investors and analysts will find timely updates on earnings reports, property acquisitions, and joint venture formations, along with regulatory filings and dividend declarations. The curated news flow emphasizes NHI's core activities in sale-leaseback transactions and specialty hospital financing.
Bookmark this page to monitor NHI's progress in capitalizing on aging population trends through its diversified portfolio of assisted living communities, memory care facilities, and skilled nursing properties. Check regularly for insights into how the company balances stable rental income with growth-oriented mezzanine financing strategies.
National Health Investors, Inc. (NHI) will release its fourth-quarter earnings results for the period ending December 31, 2021, after market close on February 22, 2022. A conference call will then be held on February 23, 2022, at 12:00 p.m. ET to discuss the results. Investors can participate by calling (800) 954-0623 using confirmation number 22014893. The call will also be streamed live online, with a replay available for one year. NHI focuses on financing senior housing and medical investments.
National Health Investors (NYSE:NHI) announced a $28.5 million development loan for constructing The Courtyard of Fitchburg, a 108-unit assisted living and memory care community in Fitchburg, WI. The loan, with an 8.5% annual interest rate and potential extensions, allows NHI to purchase the property once stabilized. NHI continues its partnership with Encore Senior Living, now operating nine properties. This strategic financing furthers NHI's growth in senior housing and medical investments.
National Health Investors (NYSE:NHI) has initiated litigation against Welltower and its subsidiaries in the Delaware Court of Chancery, claiming repeated failures to meet legal obligations. NHI alleges that Welltower fraudulently secured leases from a third party, Holiday Retirement, without honoring rental agreements. The lawsuit asserts Welltower owes over $14.1 million in back rent. The case is titled NHI v. Welltower Entities, under case number 2021-1097-MTZ.
National Health Investors (NHI) provided a business update on November 8, 2021. The company specializes in real estate investments related to senior housing and medical facilities. Its activities include sale-leaseback agreements, joint ventures, and mortgage financing. NHI's portfolio encompasses various senior living and healthcare properties. The press release also noted potential risks, including the impact of COVID-19 on tenants and borrowers, regulatory changes, and the operational success of real estate investments, which could affect NHI's financial performance.
National Health Investors (NYSE:NHI) announced a fourth quarter dividend of $0.90 per common share, payable on January 31, 2022, to shareholders of record as of December 31, 2021. The company focuses on real estate investments in senior housing and medical facilities.
NHI's portfolio includes various care communities and medical facilities, indicating a strong investment strategy within a critical healthcare sector.
National Health Investors (NHI) reported a 29.5% decrease in net income per diluted share for Q3 2021, totaling $0.67, and a 30.2% decrease for the first nine months, at $2.31. The declines stemmed from $22.5 million in impairment charges and $4.8 million in unpaid rent from Holiday Retirement. Normalized FAD and FFO also saw declines of 15.1% and 19.0% respectively for Q3. However, NHI completed property sales totaling $216 million and expects continued asset dispositions to reach the upper end of a $250-$400 million target.